Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

2(33.3%)

N/A

2(33.3%)

Phase 4

2(33.3%)

6Total

Phase 3(2)

N/A(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT04366921Unknown

European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO

Role: collaborator

NCT03651180Unknown

Efficacy and Safety of Coronary Amphilimus-ELuting Stent in diAbeTic patiEnts

Role: lead

NCT01138540Phase 3Terminated

The Gravity-VAP (Ventilator-Associated Pneumonia) Trial

Role: collaborator

NCT01828151Completed

Noninvasive Positive Airway Pressure Ventilation and Risk of Facial Pressure Ulcers

Role: lead

NCT00455611Not ApplicableWithdrawn

Effects of CPAP on Ventricular Function Modifications

Role: lead

NCT01360346Phase 3Unknown

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Role: collaborator

NCT01161849Completed

Peritoneal/ Serum Lactate Ratio in Relaparotomy

Role: lead

NCT01041768Not ApplicableUnknown

Multicentric Prospective Randomized Trial on Surgery Versus Standard Medical Care in Type 2 Diabetic Patients BMI 30-35

Role: collaborator

NCT00453726Completed

Brain Natriuretic Peptide (BNP) Levels in Patients in Non Invasive Mechanical Ventilation

Role: lead

NCT00446498Phase 4Completed

CPAP Versus NPPV in ACPE

Role: lead

NCT00453947Phase 4Completed

Non-Invasive Ventilation in Pulmonary Edema

Role: lead

All 11 trials loaded